LexDanaLexDanabeta
Inventor

Rongxin Huang

Inventor
CN

Overview

3→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes17%
G01VGeophysics17%
PatentTitleYear
12,565,4816,7-dimethoxy-3-(pyridin-2-yl)quinoline compounds for inhibiting RET202612,379,514System and method for elastic full waveform inversion and imaging202511,236,094Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD (1)· patent assignee history
2022Patents assigned to CSPC ZHONGQI PHARMACEUTICALL TECH SHIJIAZHUANG CO LTD (1)· patent assignee history
2022–2026Based in CN· patent location history
2025Patents assigned to CGG SERVICES SAS (1)· patent assignee history
2025Based in US· patent location history
2026Patents assigned to GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CGG SERVICES SAS12025
CSPC ZHONGQI PHARMACEUTICAL TECH SHIJIAZHUANG CO LTD12022
CSPC ZHONGQI PHARMACEUTICALL TECH SHIJIAZHUANG CO LTD12022
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO LTD BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY12026
Locations
LocationPatentsSpan
CN22022–2026
US12025